The Latvian Institute of Organic Synthesis (LIOS) is a public research institute with a slogan of "Cure through knowledge".LIOS boasts a wide range of expertise in the drug discovery and development process, covering medicinal chemistry, organic synthesis, in vitro and in vivo pharmacology, bioanalytical studies, computational modeling, and process chemistry. Established in 1957, the institute has a noteworthy track record in drug design and technology development, having discovered and introduced 18 original drugs to the market, as well as inventing over 70 original reparation methods for known medicines. While there is no specific information available on industries, headquarters, or recent investments and investors, LIOS's significant contributions to the pharmaceutical and healthcare sectors position it as a potential player in the biotech and life sciences industry.
There is no investment information
No recent news or press coverage available for Latvian Institute of Organic Synthesis.